Structure-Activity Relationships in Toll-Like Receptor 2-Agonists Leading to Simplified Monoacyl Lipopeptides

被引:53
|
作者
Agnihotri, Geetanjali [1 ]
Crall, Breanna M. [1 ]
Lewis, Tyler C. [1 ]
Day, Timothy P. [1 ]
Balakrishna, Rajalakshmi [1 ]
Warshakoon, Hemamali J. [1 ]
Malladi, Subbalakshmi S. [1 ]
David, Sunil A. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66047 USA
关键词
MONOPHOSPHORYL-LIPID-A; T-CELL POLARIZATION; VACCINE ADJUVANT; RESPONSES; TLR2; TH2; LIPOPOLYSACCHARIDE; SEQUESTRANTS; ACTIVATION; SECRETION;
D O I
10.1021/jm201071e
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Toll-like receptor 2-agonistic lipopeptides typified by S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-R-cystein-yl-S-serine (PAM(2)CS) compounds are potential vaccine adjuvants. In continuation of previously reported structure activity relationships on this chemotype, we have determined that at least one acyl group of optimal length (C-16) and an appropriately oriented ester carbonyl group is essential for TLR2-agonistic activity. The spacing between one of the palmitoyl ester carbonyl and the thioether is crucial to allow for an important H-bond, which observed in the crystal structure of the lipopeptide:TLR2 complex; consequently, activity is lost in homologated compounds. Penicillamine-derived analogues are also inactive, likely due to unfavorable steric interactions with the carbonyl of Ser 12 in TLR2. The thioether in this chemotype can be replaced with a selenoether. Importantly, the thioglycerol motif can be dispensed with altogether and can be replaced with a thioethanol bridge. These results have led to a structurally simpler, synthetically more accessible, and water-soluble analogue possessing strong TLR2-agonistic activities in human blood,
引用
收藏
页码:8148 / 8160
页数:13
相关论文
共 50 条
  • [1] Structure-Activity Relationships in Human Toll-like Receptor 2-Specific Monoacyl Lipopeptides
    Salunke, Deepak B.
    Shukla, Nikunj M.
    Yoo, Euna
    Crall, Breanna M.
    Balakrishna, Rajalakshmi
    Malladi, Subbalakshmi S.
    David, Sunil A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (07) : 3353 - 3363
  • [2] Structure-Activity Relationships in Toll-like Receptor-2 Agonistic Diacylthioglycerol Lipopeptides
    Wu, Wenyan
    Li, Rongti
    Malladi, Subbalakshmi S.
    Warshakoon, Hemamali J.
    Kimbrell, Matthew R.
    Amolins, Michael W.
    Ukani, Rehman
    Datta, Apurba
    David, Sunil A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (08) : 3198 - 3213
  • [3] Structure-activity relationship of synthetic Toll-like receptor 4 agonists
    Stöver, AG
    Correia, JD
    Evans, JT
    Cluff, CW
    Elliott, MW
    Jeffery, EW
    Johnson, DA
    Lacy, MJ
    Baldridge, JR
    Probst, P
    Ulevitch, RJ
    Persing, DH
    Hershberg, RM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (06) : 4440 - 4449
  • [4] Synthetic lipopeptide adjuvants and Toll-like receptor 2 -: structure-activity relationships
    Spohn, R
    Buwitt-Beckmann, U
    Brock, R
    Jung, G
    Ulmer, AJ
    Wiesmüller, KH
    VACCINE, 2004, 22 (19) : 2494 - 2499
  • [5] N-Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2
    Willems, Marian M. J. H. P.
    Zom, Gijs G.
    Khan, Selina
    Meeuwenoord, Nico
    Melief, Cornelis J. M.
    van der Stelt, Mario
    Overkleeft, Herman S.
    Codee, Jeroen D. C.
    van der Marel, Gijsbert A.
    Ossendorp, Ferry
    Filippov, Dmitri V.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) : 6873 - 6878
  • [6] Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists
    Morin, Matthew D.
    Wang, Ying
    Jones, Brian T.
    Su, Lijing
    Surakattula, Murali M. R. P.
    Berger, Michael
    Huang, Hua
    Beutler, Elliot K.
    Zhang, Hong
    Beutler, Bruce
    Boger, Dale L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (10) : 4812 - 4830
  • [7] Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands
    Hussein, Waleed M.
    Choi, Phil M.
    Zhang, Cheng
    Su, Mei
    Sierecki, Emma
    Johnston, Wayne
    Fagan, Vincent
    Alexandrov, Kirill
    Skwarczynski, Mariusz
    Gambin, Yann
    Toth, Istvan
    Simerska, Pavla
    CURRENT DRUG DELIVERY, 2017, 14 (07) : 935 - 943
  • [8] Structure-Activity Relationships in Human Toll-Like Receptor 7-Active Imidazoquinoline Analogues
    Shukla, Nikunj M.
    Malladi, Subbalakshmi S.
    Mutz, Cole A.
    Balakrishna, Rajalakshmi
    David, Sunil A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (11) : 4450 - 4465
  • [9] Toll-like Receptor 7 Selective Synthetic Oligoribonucleotide Agonists: Synthesis and Structure-Activity Relationship Studies
    Lan, Tao
    Dai, Meiru
    Wang, Daqing
    Zhu, Fu-Gang
    Kandimalla, Ekambar R.
    Agrawal, Sudhir
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) : 6871 - 6879
  • [10] The interaction of bacterial lipopeptides with Toll-like Receptor 2 heterodimers
    Ulmer, AJ
    Buwitt-Beckmann, U
    Heine, H
    Jung, G
    Brock, R
    Akira, S
    Wiesmüller, KH
    SHOCK, 2004, 21 : 9 - 9